Louks Ronald Allen's Form 4 filing
NantHealth, Inc. (NHIQ) · filed Sep 14, 2021
- Accession no.
- 0000899243-21-035924
- Filed
- Sep 14, 2021
- Trade date
- Sep 10-13, 2021
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $33.0K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Louks Ronald AllenCIK 0001706849 | Officer (Chief Operating Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 10, 2021 | Common Stock | MOption exerciseAcquired | +7,320 | $0.55 | +$4,026 | 233,177 | Direct | |
| Sep 10, 2021 | Common Stock | SSaleDisposed | −7,320 | $2.05F1 | −$15,006 | 225,857 | Direct | |
| Sep 13, 2021 | Common Stock | MOption exerciseAcquired | +9,200 | $0.55 | +$5,060 | 235,057 | Direct | |
| Sep 13, 2021 | Common Stock | SSaleDisposed | −9,200 | $1.96F2 | −$18,032 | 225,857 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 10, 2021 | Common Stock | MOption exerciseDisposed | −7,320 | $0.00 | $0 | 519,862 | Direct | |
| Sep 13, 2021 | Common Stock | MOption exerciseDisposed | −9,200 | $0.00 | $0 | 510,662 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Represents the weighted average share price of an aggregate total of 7,320 shares sold in the price range of $1.98 to $2.29 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F2
Represents the weighted average share price of an aggregate total of 9,200 shares sold in the price range of $1.96 to $1.97 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.